Overview
Treatment-emergent central sleep apnea (TECSA) refers to the onset of central sleep apnea following the initiation of certain therapies, particularly opioids or other respiratory depressants. It is characterized by pauses in breathing due to the brain's failure to signal the muscles involved in respiration 1.Diagnosis
Clinical evaluation focusing on patient history and sleep patterns 1.
Polysomnography (PSG) to confirm central apneas and rule out other sleep disorders 1.
Monitoring respiratory rate and oxygen saturation levels during treatment initiation 1.Management
First-line treatments:
- Titrate or discontinue respiratory depressant medications (e.g., opioids) 1.
- Consider non-invasive ventilation (NIV) such as adaptive servo-ventilation (ASV) or bilevel positive airway pressure (BPAP) 1.
Adjunctive treatments:
- Pharmacological interventions like acetazolamide or theophylline may be considered 1.
- Continuous positive airway pressure (CPAP) might be used in some cases, though primarily indicated for obstructive sleep apnea 1.Special Populations
Pregnancy: Specific management strategies not addressed in provided abstracts 1.
Pediatrics: No specific guidance provided in the abstracts 1.
Elderly: Careful titration of medications and close monitoring recommended due to increased sensitivity 1.
Comorbidities: Management should consider underlying conditions affecting respiratory control; tailored approaches advised 1.Key Recommendations
Evaluate and adjust respiratory depressant medications promptly upon TECSA onset (Evidence: Expert opinion) 1.
Utilize polysomnography for definitive diagnosis and monitoring of TECSA (Evidence: Expert opinion) 1.
Implement non-invasive ventilation strategies like NIV for patients unresponsive to medication adjustments (Evidence: Expert opinion) 1.References
1 Pichoff AM, Shah A, Baer J, Staab J. Successful Development and Implementation of a Surgical Response Team for Emergent Surgical Cases. Annals of surgery 2019. link